Insider sale: 24,000 THC shares reported

Thomas W. Arnst filed a Form 144 reporting a sale of 24,000 common shares on 03/02/2026.

Rhea-AI Filing Summary

Thomas W. Arnst filed a Form 144 reporting a sale of 24,000 common shares on 03/02/2026. The filing also lists restricted stock vesting entries labeled Compensation: 3,080 shares vested on 02/28/2026 and 4,920 shares vested on 03/01/2026.

Insights

Corporate Governance Specialist

Routine insider resale with recent compensation-related vesting.

The filing shows a reported sale of 24,000 common shares by Thomas W. Arnst on 03/02/2026

Two separate restricted stock vesting events are listed as Compensation for 02/28/2026 (3,080 shares) and 03/01/2026 (4,920). Timing and labels suggest routine post-vesting dispositions; cash-flow treatment is not specified in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 144 for THC disclose about insider sales?

The Form 144 reports a sale of 24,000 common shares on 03/02/2026. The filing identifies the seller as Thomas W. Arnst and records the transaction in the "Securities Sold During The Past 3 Months" section.

Did the Form 144 show any restricted stock vesting for THC insiders?

Yes. The filing lists restricted stock vesting of 3,080 shares on 02/28/2026 and 4,920 shares on 03/01/2026. Both entries are labeled as Compensation and attributed to the issuer.

Who is listed as the purchaser or broker in the filing for THC transactions?

The broker listed is Fidelity Brokerage Services LLC at an address in Smithfield, RI. The excerpt includes this broker information alongside the securities details.

Does the Form 144 excerpt state how proceeds were used or received?

The excerpt does not state the use of proceeds or who received cash value. It records the sale quantity and vesting events but does not describe cash‑flow treatment in the provided text.

How can investors verify the timing of the reported transactions for THC?

Transaction dates are included: vesting on 02/28/2026 and 03/01/2026, and a sale on 03/02/2026. These dates are shown in the filing's securities sections.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/09/2026 - 01:08 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001852128
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TENET HEALTHCARE CORP
SEC File Number	001-07293
Address of Issuer	14201 DALLAS PARKWAY DALLAS TEXAS 75254
Phone	469-893-2200
Name of Person for Whose Account the Securities are To Be Sold	Arnst Thomas W
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8000	1910794.19	86963000	03/09/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/28/2026	Restricted Stock Vesting	Issuer			3080	02/28/2026	Compensation
Common	03/01/2026	Restricted Stock Vesting	Issuer			4920	03/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Thomas W. Arnst 14201 Dallas Parkway Dallas TX 75254	Common	03/02/2026	24000	5616932.53

144: Remarks and Signature

Remarks
Date of Notice	03/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Thomas Arnst
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)